Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Minim Invasive Ther Allied Technol. 2022 Oct;31(7):1035-1040. doi: 10.1080/13645706.2022.2090004. Epub 2022 Jun 22.
Stent or endoscopic nasobiliary drainage (ENBD) catheter placement for a tight, complicated biliary stricture is still technically challenging. A thin, 4-Fr ENBD catheter (4-Fr catheter) has been developed to overcome this difficulty. The study aimed to evaluate the feasibility of the 4-Fr catheter for endoscopic biliary drainage (EBD).
We performed a retrospective review of 51 patients who underwent EBD with the 4-Fr catheter because placement of a conventional drainage catheter (CDC) had failed.
The success rate of 4-Fr catheter placement was 96.1% (49/51). The median patency period of the catheter was 114 days (95% CI, 53-200). Among the 49 patients with successful placement of the catheter, adverse events occurred in five (10.2%) patients: post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), two patients; catheter dislocation, one patient; and kinking of the 4-Fr catheter, two patients. Both cases of PEP improved with conservative treatment, but all cases of catheter dislocation and kinking required reintervention with a 4-Fr catheter. Forty-three (87.8%) patients achieved clinical remission after EBD with a 4-Fr catheter.
The newly developed 4-Fr catheter is safe and feasible for EBD in patients in whom CDC placement is difficult due to a tight, complicated biliary stricture.
对于紧、复杂的胆道狭窄,支架或内镜鼻胆管引流(ENBD)导管的放置在技术上仍然具有挑战性。已经开发出一种 4Fr 的 ENBD 导管(4Fr 导管)来克服这一困难。本研究旨在评估 4Fr 导管用于内镜胆道引流(EBD)的可行性。
我们回顾性分析了 51 例因常规引流导管(CDC)放置失败而行 EBD 并使用 4Fr 导管的患者。
4Fr 导管放置成功率为 96.1%(49/51)。导管的中位通畅期为 114 天(95%CI,53-200)。在 49 例成功放置导管的患者中,有 5 例(10.2%)发生不良事件:内镜逆行胰胆管造影术后胰腺炎(PEP),2 例;导管脱位,1 例;4Fr 导管扭结,2 例。所有 PEP 病例均经保守治疗后改善,但所有导管脱位和扭结病例均需再次使用 4Fr 导管进行干预。43 例(87.8%)患者在 EBD 后使用 4Fr 导管实现了临床缓解。
对于由于紧、复杂的胆道狭窄而难以放置 CDC 的患者,新开发的 4Fr 导管用于 EBD 是安全且可行的。